Tegmine Therapeutics

company

About

Tegmine Therapeutics is a San Francisco-based biotechnology firm.

  • 1 - 10

Details

Last Funding Type
Corporate Round
Industries
Biotechnology,Professional Services,Service Industry
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Tegmine Therapeutics is private, seed-stage biotech that develops antibody-based therapeutics targeting proteins and their disease-related glycan modifications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Tegmine Therapeutics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Apr 6, 2022 from a Corporate Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 6, 2022 Corporate Round 1 Alloy Therapeutics Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Tegmine Therapeutics is funded by 1 investors. Alloy Therapeutics are the most recent investors.
Investor Name Lead Investor Funding Round
Alloy Therapeutics Yes Corporate Round